These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28757476)

  • 101. The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations.
    Ardestani A; Maedler K
    Endocr Rev; 2018 Feb; 39(1):21-35. PubMed ID: 29053790
    [TBL] [Abstract][Full Text] [Related]  

  • 102. RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome.
    Wang C; Yang F; Chen T; Dong Q; Zhao Z; Liu Y; Chen B; Liang H; Yang H; Gu Y
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31848596
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer.
    Yousefi H; Delavar MR; Piroozian F; Baghi M; Nguyen K; Cheng T; Vittori C; Worthylake D; Alahari SK
    Biomed Pharmacother; 2022 Jul; 151():113144. PubMed ID: 35623167
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Cellular feedback dynamics and multilevel regulation driven by the hippo pathway.
    Park J; Hansen CG
    Biochem Soc Trans; 2021 Aug; 49(4):1515-1527. PubMed ID: 34374419
    [TBL] [Abstract][Full Text] [Related]  

  • 105. YAP and the Hippo pathway in pediatric cancer.
    Ahmed AA; Mohamed AD; Gener M; Li W; Taboada E
    Mol Cell Oncol; 2017; 4(3):e1295127. PubMed ID: 28616573
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The Hippo-YAP/TAZ pathway mediates geranylgeranylation signaling in breast cancer progression.
    Lin Q; Yang W
    Mol Cell Oncol; 2016 May; 3(3):e969638. PubMed ID: 27314103
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis.
    Azad T; Rezaei R; Surendran A; Singaravelu R; Boulton S; Dave J; Bell JC; Ilkow CS
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722184
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Hippo inactivation feeds tumor-initiating cells.
    Duss S; Britschgi A; Bentires-Alj M
    Breast Cancer Res; 2012 Aug; 14(4):318. PubMed ID: 22866917
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Investigating cytokinesis failure as a strategy in cancer therapy.
    McKenzie C; D'Avino PP
    Oncotarget; 2016 Dec; 7(52):87323-87341. PubMed ID: 27895316
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Targeting the Hippo Pathway for Breast Cancer Therapy.
    Wu L; Yang X
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30400599
    [TBL] [Abstract][Full Text] [Related]  

  • 111. New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics.
    He M; Zhou Z; Shah AA; Hong Y; Chen Q; Wan Y
    Cell Div; 2016; 11():4. PubMed ID: 27042197
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Hippo Pathway and Skeletal Muscle Mass Regulation in Mammals: A Controversial Relationship.
    Gnimassou O; Francaux M; Deldicque L
    Front Physiol; 2017; 8():190. PubMed ID: 28424630
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer.
    Mussell A; Frangou C; Zhang J
    Genes Dis; 2019 Dec; 6(4):335-341. PubMed ID: 31832513
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential.
    Lv L; Zhou X
    MedComm (2020); 2023 Oct; 4(5):e375. PubMed ID: 37799806
    [TBL] [Abstract][Full Text] [Related]  

  • 115. An emerging role of mTOR in lipid biosynthesis.
    Laplante M; Sabatini DM
    Curr Biol; 2009 Dec; 19(22):R1046-52. PubMed ID: 19948145
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cancer: a new role for non-canonical Hippo signaling.
    Cooper J; Giancotti FG
    Cell Res; 2017 Apr; 27(4):459-460. PubMed ID: 28244491
    [TBL] [Abstract][Full Text] [Related]  

  • 117. It takes two to tango: coupling of Hippo pathway and redox signaling in biological process.
    Zheng J; Yu H; Zhou A; Wu B; Liu J; Jia Y; Xiang L
    Cell Cycle; 2020 Nov; 19(21):2760-2775. PubMed ID: 33016196
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia.
    Yeo MK; Park HS; Park YH; Lee CS; Yoo G; Park DI; Lee JE; Moon JY; Jung SS; Kim JO; Kang D; Cho HJ; Kang MW; Kim JW; Kim SS; Chung C
    Chin Med J (Engl); 2018 Mar; 131(5):626-628. PubMed ID: 29483403
    [No Abstract]   [Full Text] [Related]  

  • 119. A shortcut for early macrophage recruitment into tumors by activated oncogenes.
    Austenaa L; Natoli G
    Genes Dev; 2017 Feb; 31(3):223-225. PubMed ID: 28270513
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment.
    Kaur S; Najm MZ; Khan MA; Akhter N; Shingatgeri VM; Sikenis M; Sadaf ; Aloliqi AA
    Breast Cancer (Dove Med Press); 2021; 13():691-700. PubMed ID: 34938116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.